The Role of BRAF in Metastatic Colorectal Carcinoma-Past, Present, and Future.

Int J Mol Sci · 2020 · PMC7729567 · PMID 33256240

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Similarly, the VELOUR trial showed a trend towards a significant increase of OS in the BRAF V600E -mutated patients treated with aflibercept.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.